| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Applied Therapeutics, Inc. (APLT) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. APLT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 1.34M | - | - | |
| Other | 841.7K | - | - | |
| Dir | 200.0K | - | - | |
| Dir | 200.0K | - | - | |
| Dir | 65.0K | $7.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Kanter Stacy J. | Director | Sell | 43,000 | $0.11 | $4,816.00 | -39.8% | - | - | |
| Mar 4, 2025 | Perfetti Riccardo84 | Chief Medical Officer | Sell | 10,366 | $0.44 | $4,561.04 | -1.2% | -26.2% | - | |
| Mar 4, 2025 | Funtleyder Leslie D.77 | See Remarks | Sell | 14,502 | $0.44 | $6,380.88 | -3.6% | -26.2% | - | |
| Mar 4, 2025 | Chinoporos Constantine | See Remarks | Sell | 447 | $0.44 | $196.68 | -0.2% | -26.2% | - | |
| Feb 6, 2025 | Funtleyder Leslie D.77 | See Remarks | Sell | 22,950 | $0.61 | $13,999.50 | -5.4% | -31.1% | -83.1% | |
| Feb 6, 2025 | Perfetti Riccardo84 | Chief Medical Officer | Sell | 86,078 | $0.61 | $52,507.58 | -8.7% | -31.1% | -83.1% | |
| Feb 6, 2025 | Chinoporos Constantine | See Remarks | Sell | 28,117 | $0.61 | $17,151.37 | -9.4% | -31.1% | -83.1% | |
| Aug 22, 2024 | Funtleyder Leslie D.77 | Chief Financial Officer | Sell | 13,530 | $5.83 | $78,879.90 | -4.6% | +68.4% | -90.9% | |
| Aug 22, 2024 | Perfetti Riccardo84 | Chief Medical Officer | Sell | 22,681 | $5.83 | $132,230.23 | -2.2% | +68.4% | -90.9% | |
| Aug 14, 2024 | Shendelman Shoshana71 | President And CEO | Sell | 777,014 | $6.06 | $4,712,048.77 | -5.0% | +67.2% | -92.0% |